Stocks · Health care · Pharmaceutical Preparations

BeOne Medicines Ltd.

ONC Clue Score63
Fiscal year ends December CIK 0001651308 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
6,903
$366.22
$2.53M
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
3,965
$365.43
$1.45M
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
2,841
$363.95
$1.03M
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
8,148
$363.24
$2.96M
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
2,331
$362.35
$844.64K
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
320
$360.64
$115.40K
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
1,280
$359.72
$460.44K
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
1,681
$358.75
$603.05K
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
1,239
$357.54
$442.99K
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
1,440
$355.62
$512.09K
Xiaodong Wang
27 Oct 2026
Director
Sold after exercise
880
$355.56
$312.89K
Xiaodong Wang
13 Oct 2026
Director
Sold after exercise
1,260
$353.24
$445.08K
Xiaodong Wang
13 Oct 2026
Director
Sold after exercise
6,558
$352.57
$2.31M
Xiaodong Wang
13 Oct 2026
Director
Sold after exercise
5,681
$351.40
$2.00M
Xiaodong Wang
13 Oct 2026
Director
Sold after exercise
10,361
$350.47
$3.63M
Xiaodong Wang
13 Oct 2026
Director
Sold after exercise
7,167
$349.56
$2.51M

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 16
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 62,055
History held since 9 Feb 2016